NIOX Group (LON:NIOX) Trading Up 3.4% – What’s Next?

NIOX Group Plc (LON:NIOX) shares traded up 3.4% during mid-day trading on Tuesday . The stock traded as high as GBX 59.17 and last traded at GBX 59.17. 2,496,140 shares were traded during trading, an increase of 191% from the average session volume of 856,313 shares. The stock had previously closed at GBX 57.20.

NIOX Group Trading Down 0.3%

The firm has a market cap of £248.31 million, a price-to-earnings ratio of 35.98 and a beta of 0.92. The company’s 50-day moving average price is GBX 59.20 and its 200-day moving average price is GBX 61.89. The company has a quick ratio of 1.94, a current ratio of 3.81 and a debt-to-equity ratio of 1.36.

Insider Transactions at NIOX Group

In other NIOX Group news, insider Sarah Duncan sold 34,219 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of GBX 58, for a total transaction of £19,847.02. Also, insider Jonathan Emms sold 69,494 shares of the firm’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of GBX 58, for a total value of £40,306.52. Over the last ninety days, insiders purchased 102,805 shares of company stock worth $5,996,817 and sold 172,171 shares worth $10,019,834. Company insiders own 5.11% of the company’s stock.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.